{"id":13335,"date":"2015-05-14T15:32:00","date_gmt":"2015-05-14T15:32:00","guid":{"rendered":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/"},"modified":"2015-05-14T15:32:00","modified_gmt":"2015-05-14T15:32:00","slug":"allergan-es-la-ultima-empresa-en-abandonar-alec-mientras-aumenta-la-presion-sobre-pfizer","status":"publish","type":"article","link":"https:\/\/www.commoncause.org\/es\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/","title":{"rendered":"Allergan, la \u00faltima empresa en abandonar ALEC mientras aumenta la presi\u00f3n sobre Pfizer"},"template":"","class_list":["post-13335","article","type-article","status-publish","hentry","article_type-blog-post"],"acf":{"details":{"summary":"Another major corporation has decided to leave the controversial corporate lobbying group the American Legislative Exchange Council (ALEC), Common Cause has learned.","featured_image":null,"article_type":1103,"authors":["{\"site_id\":\"1\",\"post_type\":\"person\",\"post_id\":8296}"],"related_issues":false,"related_work":false,"location":null},"sidebar":{"helper_enable_sidebar":false,"helper_media_contact":{"heading":"Media Contact","manually_enter_person":false,"person":null,"name":"","role":"","phone":"","email":""},"helper_links_downloads":{"heading":"Links & Downloads","links":null}},"page_layout":[{"acf_fc_layout":"layout_wysiwyg","_acfe_flexible_toggle":null,"component_wysiwyg":{"content":"

Otra gran corporaci\u00f3n ha decidido abandonar el pol\u00e9mico grupo de lobby corporativo American Legislative Exchange Council (ALEC), seg\u00fan ha sabido Common Cause.<\/strong><\/p>

Allergan, una compa\u00f1\u00eda farmac\u00e9utica de $7.2 mil millones recientemente adquirida por Actavis, le dijo a Common Cause que "ya no es un miembro activo de ALEC". Allergan fue previamente<\/a> Copresidente corporativo estatal de ALEC en Tennessee y miembro del Grupo de Trabajo de Salud y Servicios Humanos de ALEC. Los registros muestran que Allergan tambi\u00e9n fue anteriormente... principal financiador<\/a> del fondo de \u201cbecas\u201d de ALEC, un fondo secreto corporativo donde los pol\u00edticos pueden conseguir viajes gratis para asistir a las reuniones de ALEC.<\/p>

La salida de la compa\u00f1\u00eda se produce a medida que aumenta la presi\u00f3n sobre el gigante farmac\u00e9utico Pfizer para que cancele su membres\u00eda en ALEC. En marzo, m\u00e1s de 80 organizaciones enviaron a los ejecutivos de Pfizer una carta<\/a> instando a la corporaci\u00f3n a abandonar ALEC. En Pfizer Junta anual de accionistas en abril<\/a>Los inversores y los defensores del inter\u00e9s p\u00fablico pidieron nuevamente a la empresa que ponga fin a su membres\u00eda en ALEC y revele m\u00e1s sobre sus gastos pol\u00edticos y de lobby.<\/p>

Justo esta semana, Common Cause y el Centro para los Medios y la Democracia present\u00f3 nuevas pruebas al IRS<\/a> sobre la condici\u00f3n de organizaci\u00f3n ben\u00e9fica sin fines de lucro de ALEC y sus actividades ilegales de cabildeo, que inclu\u00edan una carta de Pfizer que destacaba c\u00f3mo la empresa utiliza a ALEC para impulsar leyes. Aunque Pfizer ha declarado<\/a> no est\u00e1 de acuerdo con ALEC sobre el cambio clim\u00e1tico y es miembro de ALEC para trabajar espec\u00edficamente en cuestiones de pol\u00edtica de salud, la carta de Pfizer tambi\u00e9n revel\u00f3 que la compa\u00f1\u00eda se uni\u00f3 a un comit\u00e9 de medio ambiente y energ\u00eda de ALEC para trabajar en cuestiones de cambio clim\u00e1tico dentro de ALEC en 2014. <\/p>

<\/strong>Common Cause continues to call on Pfizer to leave ALEC -- join us!<\/strong><\/a><\/p>

Allergan se une ahora a numerosas compa\u00f1\u00edas farmac\u00e9uticas que han cortado v\u00ednculos con ALEC en los \u00faltimos a\u00f1os, como Johnson & Johnson, GlaxoSmithKline, Merck, Bristol-Myers Squibb y Sanofi. Durante el \u00faltimo a\u00f1o, ALEC se ha enfrentado a un \u00e9xodo corporativo, ya que numerosas empresas han cortado v\u00ednculos con la organizaci\u00f3n debido a su controvertida postura sobre el cambio clim\u00e1tico y a las preocupaciones legales sobre su condici\u00f3n de organizaci\u00f3n ben\u00e9fica sin fines de lucro. Microsoft, Google, Facebook, Yelp, Yahoo, International Paper, Occidental Petroleum, News Corp, SAP, AOL, eBay, Northrop Grumman, BP y T-Mobile han confirmado que han abandonado o planean abandonar ALEC en los \u00faltimos diez meses.<\/p>

 \u00a1Con tu ayuda, Pfizer ser\u00e1 el pr\u00f3ximo!<\/strong><\/a>
<\/strong><\/p>"}}]},"yoast_head":"\nAllergan Latest Company to Leave ALEC as Pressure Builds on Pfizer - Common Cause<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.commoncause.org\/es\/articulos-2\/allergan-es-la-ultima-empresa-en-abandonar-alec-mientras-aumenta-la-presion-sobre-pfizer\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.commoncause.org\/es\/articulos-2\/allergan-es-la-ultima-empresa-en-abandonar-alec-mientras-aumenta-la-presion-sobre-pfizer\/\" \/>\n<meta property=\"og:site_name\" content=\"Common Cause\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CommonCause\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/10\/CC-Share-Graphic-Main9.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@CommonCause\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/\",\"url\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/\",\"name\":\"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer - Common Cause\",\"isPartOf\":{\"@id\":\"https:\/\/www.commoncause.org\/#website\"},\"datePublished\":\"2015-05-14T15:32:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.commoncause.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.commoncause.org\/#website\",\"url\":\"https:\/\/www.commoncause.org\/\",\"name\":\"Common Cause\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.commoncause.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.commoncause.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.commoncause.org\/#organization\",\"name\":\"Common Cause\",\"url\":\"https:\/\/www.commoncause.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png\",\"contentUrl\":\"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png\",\"width\":2066,\"height\":331,\"caption\":\"Common Cause\"},\"image\":{\"@id\":\"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CommonCause\",\"https:\/\/x.com\/CommonCause\",\"https:\/\/www.instagram.com\/ourcommoncause\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Allergan, la \u00faltima empresa en abandonar ALEC mientras aumenta la presi\u00f3n sobre Pfizer - Causa Com\u00fan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.commoncause.org\/es\/articulos-2\/allergan-es-la-ultima-empresa-en-abandonar-alec-mientras-aumenta-la-presion-sobre-pfizer\/","og_locale":"es_MX","og_type":"article","og_title":"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer","og_url":"https:\/\/www.commoncause.org\/es\/articulos-2\/allergan-es-la-ultima-empresa-en-abandonar-alec-mientras-aumenta-la-presion-sobre-pfizer\/","og_site_name":"Common Cause","article_publisher":"https:\/\/www.facebook.com\/CommonCause","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/10\/CC-Share-Graphic-Main9.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@CommonCause","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/","url":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/","name":"Allergan, la \u00faltima empresa en abandonar ALEC mientras aumenta la presi\u00f3n sobre Pfizer - Causa Com\u00fan","isPartOf":{"@id":"https:\/\/www.commoncause.org\/#website"},"datePublished":"2015-05-14T15:32:00+00:00","breadcrumb":{"@id":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.commoncause.org\/"},{"@type":"ListItem","position":2,"name":"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer"}]},{"@type":"WebSite","@id":"https:\/\/www.commoncause.org\/#website","url":"https:\/\/www.commoncause.org\/","name":"Causa com\u00fan","description":"","publisher":{"@id":"https:\/\/www.commoncause.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.commoncause.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.commoncause.org\/#organization","name":"Causa com\u00fan","url":"https:\/\/www.commoncause.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png","contentUrl":"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png","width":2066,"height":331,"caption":"Common Cause"},"image":{"@id":"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CommonCause","https:\/\/x.com\/CommonCause","https:\/\/www.instagram.com\/ourcommoncause\/"]}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Common Cause","distributor_original_site_url":"https:\/\/www.commoncause.org\/es","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.commoncause.org\/es\/wp-json\/wp\/v2\/article\/13335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.commoncause.org\/es\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/www.commoncause.org\/es\/wp-json\/wp\/v2\/types\/article"}],"version-history":[{"count":0,"href":"https:\/\/www.commoncause.org\/es\/wp-json\/wp\/v2\/article\/13335\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.commoncause.org\/es\/wp-json\/wp\/v2\/media?parent=13335"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}